Anne Cambon-Thomsen

Anne Cambon-Thomsen, MD, is Director of Research in CNRS (French national centre for scientific research). Specialist in human immunogenetics, holding also a degree in health ethics, she presently leads a multidiciplinary research team on “Genomics, biotherapies and public health”, involving human and social sciences as well as health sciences, in the context of research in epidemiology and public health at Inserm (National Institute for Health and Medical Research), and University of Toulouse III Paul Sabatier, joint Unit 1027) at the Faculty of Medicine Toulouse-Purpan. She also leads a “Genetics and Society” platform at the Toulouse-Midi-Pyrénées Genopole. She is involved in several EU projects in genomic sciences, public health genomics and biobanks, where she is responsible of ethical, legal and social aspects. She has been rapporteur of an EU expert group on ethical, legal and social aspects of genetic testing; she sits in several scientific advisory boards such as the CEPH, and several international projects and was member of the scientific council of Inserm until 2012; she is member of the board of the European and French Societies of Human Genetics and of the French rare diseases Foundation and participates in the ICGC (Int Cancer genomics consortium). She is member of the deontology committee of INCa (National institute on Cancer) and a former member of the CCNE (French national advisory bioethics committee, 2002-2005) and of the European Group on ethics of science and new technologies (2005- 2010) and has Chaired the Life sciences operational ethics committee in CNRS (2006-2011). She worked in recent years on societal aspects of biobanks, biotherapies and genetic testing. ;